Myeloperoxidase, oxidative stress, and diseases: can we stop it ?

Samira--Redox-Speaker-2019The Scientific Committee of Paris Redox 2019 will be welcoming Dr. Semira Galijasevic, from the Sarajevo School of Science and Technology, Sarajevo Medical School, Bosnia, for the 21st International Conference on Oxidative Stress Reduction, Redox Homeostasis and Antioxidants.

Dr. Galijasevic will be presenting her studies entitled "Myeloperoxidase, oxidative stress, and diseases- can we stop it ?".

Myeloperoxidase (MPO), hemoprotein present in neutrophils and monocytes, has an essential role in immune surveillance and host defense mechanisms. Although MPO clearly plays a beneficial role, it is also implicated in promoting inflammatory tissue injury and contributing to the pathogenesis of a number of chronic inflammatory diseases.  This apparently contradictory behavior arises because the reactive chemical species (ROS and RNS) that  MPO forms to execute its bactericidal, fungicidal, and viricidal functions are also capable of damaging normal host tissues. 

For more information about Paris Redox 2019: